Our understanding of the pathogenesis and therapy of heart failure has
evolved through three paradigms. Organ physiology, the first paradigm
, focused therapy of heart failure on salt and water retention and vas
oconstriction, which represent major circulatory responses to, cardiac
pumping. The second paradigm of cell biochemistry led to the developm
ent of powerful inotropic agents designed to increase myocardial contr
actility. The third paradigm, gene expression (molecular biology), des
cribes regulatory mechanisms that are both primitive and complex; in t
he setting of heart failure, this paradigm focuses on the roles of alt
ered myocardial cell growth and composition in explaining the accelera
ted deterioration of the hypertrophied, failing heart. This review foc
uses on one aspect of the second paradigm: factors that contribute to
a state of energy-starvation and the resulting functional consequences
in the failing heart.